Order Article Reprints

Cipolletti M, Bartoloni S, Busonero C, Parente M, Leone S, Acconcia F. A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International Journal of Molecular Sciences. 2021; 22(6):2915. https://doi.org/10.3390/ijms22062915

Cipolletti, Manuela, Stefania Bartoloni, Claudia Busonero, Martina Parente, Stefano Leone, and Filippo Acconcia. 2021. "A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells" International Journal of Molecular Sciences 22, no. 6: 2915. https://doi.org/10.3390/ijms22062915

Cipolletti, M., Bartoloni, S., Busonero, C., Parente, M., Leone, S., & Acconcia, F. (2021). A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International Journal of Molecular Sciences, 22(6), 2915. https://doi.org/10.3390/ijms22062915